News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
68 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21652)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
BioMidwest
Skyline Medical Issues Letter to Shareholders
The company laid out some of the plans Skyline’s management team has been working toward over the past several months.
December 8, 2017
·
10 min read
Biotech Bay
sRNAlytics to Accelerate its Biomarker Discovery Platform and Services at IndieBio
sRNAlytics announced today it will participate in the IndieBio Accelerator Program in San Francisco, CA.
December 8, 2017
·
3 min read
Lone Star Bio
Seno Medical Instruments Announces New Data Demonstrating That Imagio Opto-Acoustic Breast Imaging System Delivers Critical Diagnostic and Prognostic Information About Tumor Subtypes
The prospective, multi-center study was conducted at 16 centers in the United States.
December 8, 2017
·
5 min read
Drug Development
Lilly’s Cyramza Fails to Improve Overall Survival in Phase III Gastric Cancer Study
The trial met its primary endpoint of progression-free survival but did not improve overall survival, a secondary endpoint.
December 8, 2017
·
22 min read
Pharm Country
Fox Chase Cancer Center Researchers Seek Breast Cancer Biomarkers That Indicate Immunotherapy Responsiveness
A small, but significant proportion of patients with invasive breast cancer have at least one of three biomarkers linked to ICB therapy, suggesting a role for such treatment for certain breast cancers, a new study shows.
December 8, 2017
·
1 min read
Business
Aeterna Zentaris Interim CFO Departs, Effective Immediately
The Company is currently reviewing its resource requirements with respect to its finance department and has commenced a search for Mr. Whitnell’s replacement as principal financial officer.
December 8, 2017
·
1 min read
Business
Genovis Signs Distribution Agreement in India
Genovis is continuing to expand in Asia and has signed a distribution agreement with Allianz Bioinnovation for the Indian market.
December 8, 2017
·
2 min read
Drug Development
Radius Investigational Drug Elacestrant (RAD1901) Continues to Show Promise in Advanced ER+ / HER2- Breast Cancer at the 2017 San Antonio Breast Cancer Symposium
Elacestrant recently received Fast Track designation from the U.S. Food and Drug Administration.
December 8, 2017
·
7 min read
Drug Development
ERYTECH’s Lead AML Drug Flunks Phase II Test
The study enrolled a total of 123 patients at 30 European sites.
December 8, 2017
·
7 min read
Bio NC
Fennec Announces Proposed Public Offering of Common Shares
In addition, Fennec intends to grant the underwriters a 30-day option to purchase up to an additional 15% of its common shares offered in the public offering.
December 8, 2017
·
4 min read
Previous
6 of 7
Next